| Obesity |
1 |
1 |
| Bariatric Surgery |
0 |
0.73 |
| Weight Loss |
0 |
0.63 |
| Weight Management |
0 |
0.54 |
| Biliary Disease |
0 |
0.5 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.48 |
| Fatty Liver |
0 |
0.45 |
| Liver Disease |
0 |
0.45 |
| Liver |
0 |
0.42 |
| Lipids Management |
0 |
0.41 |
| Cardiovascular Risk Management |
0 |
0.31 |
| Incretin Hormone |
0 |
0.28 |
| Cardiometabolic Risk Factors |
0 |
0.22 |
| LDL Cholesterol |
0 |
0.22 |
| Blood |
0 |
0.21 |
| Metabolism |
0 |
0.21 |
| Receptors |
0 |
0.21 |
| Type 2 Diabetes Mellitus |
0 |
0.21 |
| Board Certification |
0 |
0.14 |
| Heart |
0 |
0.14 |
| Lipoproteins |
0 |
0.14 |
| Triglycerides |
0 |
0.14 |
| Hypertension |
0 |
0.13 |
| Healthcare and Medical Technology |
0 |
0.11 |
| Antiemetic |
0 |
0.07 |
| Chronic Disease |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Drug Development |
0 |
0.07 |
| Dyslipidemia |
0 |
0.07 |
| Endocrinology |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Hyperlipidemia |
0 |
0.07 |
| Kidney |
0 |
0.07 |
| New York |
0 |
0.07 |
| Nonalcoholic Steatohepatitis |
0 |
0.07 |
| Surgery |
0 |
0.07 |